Celgene shares crater after 3Q revenue miss, lower forecast

Celgene shares crater after 3Q revenue miss, lower forecast


It narrowed its 2017 earnings forecast range Thursday and said it now expects about $13 billion in revenue this year. It previously forecast of $13 billion to $13.4 billion.



from Biotech News
Share:

Комментариев нет:

Отправить комментарий

Pharmacy News Digest

Архив блога